Sensitivity to cobalt and/or vitamin B12 due to the risk of anaphylaxis.

Patients with early Leber disease suffered severe and rapid optic atrophy when they received treatment with cyanocobalamin.

Aluminum is present in the preparation of cyanocobalamin. CNS and bone toxicity secondary to aluminum accumulation is possible in patients with renal impairment. Thus, it is a relative contraindication to cyanocobalamin.

According to the manufacturer's product labeling, cyanocobalamin formulation contains benzyl alcohol. Benzyl Alcohol is associated with fatal "Gasping Syndrome" in premature infants.